Swiss drugmaker Novartis to spin off generics unit Sandoz

The Basel-based company, which makes a vast array of drugs including cancer treatment Gleevec and Diovan for hypertension, says it wants to focus on its core innovation business that is built around therapeutics and technology such as gene and cell therapy.

from News-Economic Times https://ift.tt/YnU7y2P
via IFTTT

Comments

Popular posts from this blog

British PM Keir Starmer attempts post-Brexit reset with Europe visits

Lok Sabha Elections 2024: Nail art & society events, marathons help Jalgaon voter turnout race past 53%